Literature DB >> 1518866

Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2.

L Pascoe1, K M Curnow, L Slutsker, J M Connell, P W Speiser, M I New, P C White.   

Abstract

Glucocorticoid-suppressible hyperaldosteronism (GSH) is an autosomal dominant form of familial hypertension. The biochemical abnormalities seen in this disorder may be remedied by administration of dexamethasone, implying that aldosterone synthesis is being abnormally regulated by corticotropin. The final three steps of aldosterone synthesis, 11 beta- and 18-hydroxylation and 18-oxidation, are mediated by a cytochrome P450 in the zona glomerulosa of the adrenal cortex termed CYP11B2. A related isozyme in the zona fasciculata, CYP11B1, is required for cortisol synthesis; this isozyme, which is normally expressed at much higher levels than CYP11B2, only has 11 beta-hydroxylase activity. These isozymes are encoded by genes on human chromosome 8q22. We have now studied four unrelated patients with GSH. We found that each patient has one chromosome that carries three CYP11B genes instead of two. This has presumably been generated by unequal meiotic crossing-over. The extra gene is a hybrid with 5' regulatory and coding regions corresponding to CYP11B1 and 3' coding regions from CYP11B2. The breakpoint is in intron 2 in two cases, intron 3 in one, and exon 4 in one. Cells transfected with hybrid cDNAs containing up to the first three exons of CYP11B1 synthesized aldosterone at levels near that of cells carrying normal CYP11B2, but cells transfected with hybrids containing the first five or more exons of CYP11B1 could not synthesize detectable amounts of aldosterone. These data demonstrate that GSH is caused by expression of a gene that is regulated like CYP11B1 but that encodes a protein able to synthesize aldosterone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1518866      PMCID: PMC49911          DOI: 10.1073/pnas.89.17.8327

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Genetic basis of endocrine disease 2: congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  P C White; M I New
Journal:  J Clin Endocrinol Metab       Date:  1992-01       Impact factor: 5.958

2.  Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency.

Authors:  L Pascoe; K M Curnow; L Slutsker; A Rösler; P C White
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  Mineralocorticoids, salt balance and blood pressure after prolonged ACTH administration in juvenile hypertension.

Authors:  W Rauh; L S Levine; K Gottesdiener; M I New
Journal:  Klin Wochenschr       Date:  1978

4.  Autosomal dominant transmission and absence of HLA linkage in dexamethasone suppressible hyperaldosteronism.

Authors:  M I New; S E Oberfield; L S Levine; B Dupont; M Pollack; J R Gill; F C Bartter
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

5.  Different isozymes of mouse 11 beta-hydroxylase produce mineralocorticoids and glucocorticoids.

Authors:  L J Domalik; D D Chaplin; M S Kirkman; R C Wu; W W Liu; T A Howard; M F Seldin; K L Parker
Journal:  Mol Endocrinol       Date:  1991-12

6.  Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism.

Authors:  S Ulick; C K Chan; J R Gill; M Gutkin; L Letcher; F Mantero; M I New
Journal:  J Clin Endocrinol Metab       Date:  1990-11       Impact factor: 5.958

7.  Aldosterone synthase cytochrome P-450 expressed in the adrenals of patients with primary aldosteronism.

Authors:  T Ogishima; H Shibata; H Shimada; F Mitani; H Suzuki; T Saruta; Y Ishimura
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

8.  A mutation in CYP11B1 (Arg-448----His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin.

Authors:  P C White; J Dupont; M I New; E Leiberman; Z Hochberg; A Rösler
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

9.  The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex.

Authors:  K M Curnow; M T Tusie-Luna; L Pascoe; R Natarajan; J L Gu; J L Nadler; P C White
Journal:  Mol Endocrinol       Date:  1991-10

10.  A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.

Authors:  R P Lifton; R G Dluhy; M Powers; G M Rich; S Cook; S Ulick; J M Lalouel
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

View more
  34 in total

1.  A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21.

Authors:  D H Cohn; T Shohat; M Yahav; T Ilan; G Rechavi; L King; M Shohat
Journal:  Am J Hum Genet       Date:  2000-08-04       Impact factor: 11.025

2.  Studies on the origin of circulating 18-hydroxycortisol and 18-oxocortisol in normal human subjects.

Authors:  E Marie Freel; Loai A Shakerdi; Elaine C Friel; A Michael Wallace; Eleanor Davies; Robert Fraser; John M C Connell
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

3.  A revised evolutionary history of the CYP1A subfamily: gene duplication, gene conversion, and positive selection.

Authors:  Heather M H Goldstone; John J Stegeman
Journal:  J Mol Evol       Date:  2006-04-28       Impact factor: 2.395

4.  Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.

Authors:  Kenji Oki; Maria W Plonczynski; Milay Luis Lam; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

Review 5.  Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review.

Authors:  Lina Schiffer; Lise Barnard; Elizabeth S Baranowski; Lorna C Gilligan; Angela E Taylor; Wiebke Arlt; Cedric H L Shackleton; Karl-Heinz Storbeck
Journal:  J Steroid Biochem Mol Biol       Date:  2019-07-27       Impact factor: 4.292

6.  Structural insights into aldosterone synthase substrate specificity and targeted inhibition.

Authors:  Natallia Strushkevich; Andrei A Gilep; Limin Shen; Cheryl H Arrowsmith; Aled M Edwards; Sergey A Usanov; Hee-Won Park
Journal:  Mol Endocrinol       Date:  2013-01-15

7.  Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms.

Authors:  M T Tusié-Luna; P C White
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

8.  Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree.

Authors:  L Pascoe; X Jeunemaitre; M C Lebrethon; K M Curnow; C E Gomez-Sanchez; J M Gasc; J M Saez; P Corvol
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

Review 9.  Role of KCNJ5 in familial and sporadic primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; William E Rainey; Franco Veglio; Tracy Ann Williams
Journal:  Nat Rev Endocrinol       Date:  2012-12-11       Impact factor: 43.330

Review 10.  DIAGNOSIS OF ENDOCRINE DISEASE: 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids?

Authors:  Jacques W M Lenders; Tracy Ann Williams; Martin Reincke; Celso E Gomez-Sanchez
Journal:  Eur J Endocrinol       Date:  2017-09-13       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.